Stroke Prevention in Nigeria 2 Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.
Also called NCT06526117
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 220 participants
- Sponsor
- Registry
-
NCT06526117
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Nigeria
- Registry status
- Recruiting
Technical summary
Registry record NCT06526117. Allocation not applicable; no masking; primary purpose prevention. Start 2024-08-05 (actual); primary completion 2029-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stroke Prevention in Nigeria 2 Trial
- Acronym
- SPRING-2
- Condition
- Sickle Cell Disease
- Condition
- Stroke
- Intervention (Drug)
- Hydroxyurea
- Lead sponsor
- Vanderbilt University Medical Center
- Collaborator
- Aminu Kano Teaching Hospital
- Collaborator
- Murtala Muhammed Specialist Hospital
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
Record details
- Record id
cardio:ct-nct06526117- Content hash
d01e7d62458977241a686ea227c57526297f1dcb3d97c1884975aa38365f7268